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 ABSTRACT 
 
THE PREVALENCE OF TM7a IN HUMAN SUBGINGIVAL PLAQUE 
 
by Jamsheed Ghadiri 
 
Most bacteria are yet to be cultivated, and some uncultivated bacteria have been 
associated with human diseases. TM7, an uncultivated candidate division of bacteria, has 
been recently associated with periodontitis, a disease if left untreated causes tooth 
degradation and gum decay. A subgroup of TM7, known as TM7a, has been found in 
both human samples and activated wastewater.  TM7a from these two locations are as 
high as 99.7% similar by 16S rRNA gene sequence analysis, leading researchers to 
believe both TM7a strains are very similar functionally.  TM7a has been extensively 
studied in activated wastewater. However, little is known of its prevalence in the human 
oral cavity.  This research surveyed for the first time the prevalence of TM7a in human 
subgingival plaque by using a quantitative PCR assay (qPCR) optimized for this study.  
The oral cavities of six healthy individuals were sampled.  A total of 34 subgingival 
plaque samples were collected from 5 – 6 teeth per patient.  It was determined by qPCR 
that TM7a was present in five of six (83%) patients and in 22 of 34 (64.7%) samples.  
The average abundance of TM7a in the human oral cavity was 3.36x10
7 
± 2.53x10
6
    
cells g
-1
 and comprised 2.88x10
-1 
% ± 2.16x10
-1
% – 1.00x10-3% ± 8.65x10-4% total 
bacteria.  TM7a was also found to be significantly more abundant in plaques collected 
from the facial sites (p < 0.0005), and in posterior sites (p < 0.05).  These data suggest 
that the prevalence of TM7a is dynamic in the human oral cavity and provides the basis 
for a potential large-scale study to quantify TM7a in a population.
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1 
Introduction 
 
The vast majority of the bacterial diversity known today consists of strains that 
cannot yet be grown in pure culture under laboratory conditions. Since molecular 
techniques were first applied to identify bacteria, the number of known phylum-level 
lineages increased from 12 (Woese, 1987) to over 100 (Sogin, 2009), most of which are 
known as candidate divisions as its members are yet to be cultivated.  An estimated 68% 
of the human oral flora is composed of uncultured bacteria (Dewhirst et al. 2010).  Some 
of these uncultivated bacteria have been associated with human oral disease, promoting 
an increased effort to understand their role in this infected site (Brinig et al., 2003; 
Lawson et al., 1998). 
The candidate division TM7 has been detected in a variety of organisms and 
environmental sources including garden soil, fresh and marine water, activated 
wastewater (Dinis et al., 2011), canines (Dewhirst et al., 2012), and humans (Brinig et al., 
2003; Dewhirst et al., 2010; Dinis et al. 2011).  In humans, TM7 has been associated with 
the human oral disease, periodontitis, a disease that if left untreated causes tooth and gum 
decay (Brinig et al., 2003). 
Recently, a subgroup of TM7 known as TM7a was detected on human skin and in 
the oral cavity. Interestingly, in 2011, TM7a was also detected in activated wastewater in 
San Jose, CA (Dinis et al., 2011).  In that study, it was determined that the similarity 
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between human oral TM7a and wastewater TM7a was 99.7% based on 16S rDNA gene 
sequence analysis. However, TM7a has not been quantified in the human oral cavity. 
In this pilot study, I quantified and determined the prevalence of TM7a in the 
human oral cavity.  The oral cavities of six healthy individuals were sampled.  A total of 
34 subgingival plaque samples were collected from 5 – 6 teeth per patient.  
Quantification of TM7a was performed using an optimized assay I adapted from Dinis et 
al. (2011) to understand the prevalence of TM7a in human subgingival plaque. 
  
3 
Literature Review 
 
Uncultivated Bacteria 
 
In the late 1970s, Carl Woese used molecular techniques to redefine the tree of 
life (Woese, 1987).   Relying on conserved genes (e.g., the small subunit of the ribosomal 
gene, referred to here either as 16S rDNA or 16S rRNA gene), he discovered a clear 
distinction within prokaryotes where the kingdom was split into two domains: Archaea 
and Eubacteria.  In subsequent years, the 16S rRNA gene became the standard marker to 
identify bacteria, due to its conserved nature and ideal length for PCR (Lane, 1991).  In 
the 1990s, researchers developed universal primers to target the 16S rRNA gene based on 
known sequencing data (Lane, 1991).  These universal bacterial primers have been 
utilized to target bacteria within various samples sites.  Since their inception, the number 
of known bacterial phyla has been increased from 12 (Woese, 1987) to over 100 (Sogin, 
2009).  As new bacterial domains were discovered, so were the number of phyla 
represented only by uncultured bacteria.  These phyla are known as “candidate divisions” 
as there are no known cultured representatives and their existence is solely based on 16S 
rRNA gene studies (Hugenholtz et al., 1998).  Over 99% of bacteria remain uncultivated 
(Hugenholtz et al., 1998; Rappé and Giovannoni, 2003).  Many of these bacteria thrive in 
mixed microbial communities with diverse metabolic byproducts and complex microbial 
interactions, which have proven difficult to replicate in culturing media (Lewis et al., 
2010; Schmidt and Konopka, 2009).  Furthermore, some uncultivated bacteria have been 
associated with human diseases, such as gastroenteritis and periodontitis, pushing the 
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effort to cultivate these bacteria in order to understand their role in infected sites and 
mixed microbial communities (Brinig et al., 2003; Lawson et al., 1998). 
 
TM7 Bacteria 
 
The candidate division TM7 is one of the most extensively studied uncultivated 
divisions yet still contains no cultured representatives.  TM7 was first discovered in a 
German peat bog by targeting the 16S rRNA gene (Hugenholtz et al., 2001).  In that 
study, the name TM7 was derived from the nomenclature used to identify sequence 
clones.  TM7 stood for: Torf, mittlere Schicht, or peat, middle layer, clone number 7, 
from which the division took its name.  Further studies revealed TM7’s ubiquitous nature 
in the environment, having been found in environmental sites including garden soil, fresh 
and marine water, and activated wastewater (Hugenholtz et al., 2001; Dinis et al. 2011).  
TM7 has also been found in organisms, including marine sponges (Hardoim et al., 2009), 
canines (Dewhirst et al., 2012), termites (Hugenholtz et al., 2001), and humans (Brinig et 
al., 2003; Dinis et al., 2011).  Fluorescent in situ hybridization (FISH) observations have 
characterized the morphologies of TM7 which range from cocci, bacilli, and filaments 
(Ouverney et al. 2003).  The size of cocci shaped TM7 cells average 0.5 μm in diameter, 
and 1.0 to 5.0 μm for individual bacilli cells (Hugenholtz et al., 2001).  Transmission 
electron microscopy of TM7 cells has identified a cellular structure similar in 
composition to that of Gram-positive bacteria; consequently, it is thought that TM7 is a 
gram-positive bacterium (Albertsen et al. 2013; Hugenholtz et al., 2001).  
5 
TM7 in Human Sites 
 
In humans, TM7 has been discovered in a variety of anatomical locations 
including the skin, esophagus, intestine, and the oral cavity (Brinig et al., 2003; Gao et al., 
2007; Kuehbacher et al., 2008; Pei et al., 2004).  The most extensively studied location is 
within the human oral cavity, of which a subdivision of TM7, known as ‘SBG1’ has been 
associated with chronic periodontitis (Brinig et al., 2003). Periodontitis is characterized 
by the onset of ovular bone degradation caused by bacteria (Oliver et al., 1991).  In a 
study by Brinig et al. (2003), SBG1 was found to exist in significantly higher abundances 
in periodontal patients than in healthy patients (p < 0.001; Fisher’s exact test).  
Furthermore, SBG1 cells were longer in diseased sites than in healthy sites (p = 0.003; 
unpaired t test) (Brinig et al., 2003; Ouverney et al. 2003).  In another study, TM7 was 
found in all 12 patients with periodontitis and only in 4 out of 9 without (Kumar et al., 
2003).  Due to TM7’s increased prevalence in periodontal sites, TM7 is now associated 
with periodontitis and is it is believed that SBG1 may be necessary for the development 
of biofilms in these diseased sites (Brinig et al., 2003; Kumar et al., 2003).  Additionally, 
TM7 has been associated with cystic fibrosis, inflammatory bowel disease, and vaginosis 
(Fredricks et al., 2007; Guss et al., 2010; Kuehbacher et al., 2008). 
  
6 
TM7 Phylogeny 
 
Over the past decade, efforts to establish the phylogeny of TM7 based on 16S 
rDNA sequences have been made.  TM7 was first thought to contain three monophyletic 
subdivisions (Hugenholtz et al., 2001).  However, the most recent phylogenetic 
representation of TM7 suggests two monophyletic subdivisions (Dinis et al., 2011).  In 
the most recent study, Dinis et al. (2011) utilized all 255 representative TM7 sequences 
from the Genebank public database to create the most accurate and up-to-date 
phylogenetic representation of TM7 yet.  Among the 255 TM7 sequences included in the 
Dinis et al. phylogenetic tree, 160 were classified as environmental, 53 as human-
associated, and 42 as animal (non-human) associated (Dinis et al., 2011).  Human-
associated and animal-associated TM7 sequences predominantly clustered in one 
subdivision and environmental TM7 in the second.  That suggested TM7 bacteria 
associated with human and animal hosts shared an evolutionary history not shared by 
most environmental TM7.  For a few exceptions, however, some TM7 from the 
environment had greater homology to the human-associated TM7 than to other 
environmental TM7.  One novel finding in that study was a clade of TM7 (called TM7a) 
that included sequences retrieved from wastewater and from the human oral cavity and 
skin (Dinis et al. 2011). TM7a from these two locations are as high as 99.7% similar 
based on 16S rDNA sequence comparisons (Dinis et al., 2011).  Such level of percent 
similarity insinuates the TM7a found in wastewater and TM7a associated with humans 
belong to the same species.  However, the prevalence and abundance of TM7a in human 
subgingival plaque remains unknown. 
7 
TM7 Genomic Analysis 
 
Beyond the 16S rRNA single gene approach, genomic sequences can provide a 
more in-depth analysis by defining genes that are responsible for various functions within 
the bacterium.  Most of the metabolic and physiological data responsible for the 
functional understanding of many uncultivated bacteria was derived from genomic 
sequences. Several studies have acquired partial genomic sequences of TM7, one study 
was performed in the human oral cavity (Marcy et al. 2007), the other in soil (Podar et al. 
2007).  These studies made use of multiple displacement amplification (MDA) to amplify 
individual cells isolated by either microfluidic devices (Marcy et al., 2007) or via cell 
sorting using flow cytometry (Podar et al., 2007).  In the human oral cavity, 1,474 genes 
were discovered from oral TM7 clone TM7a (Marcy et al., 2007).  In soil, whole genome 
amplification recovered 670 genes from TM7 clone GTL-1 (Podar et al., 2007). Gene 
comparisons found that only 20% of the predicted TM7 proteins had >60% homology to 
previously sequenced proteins. That means most genes from TM7 are novel, with low 
similarity to any other gene studied so far.  Furthermore, a third (33.3%) of the predicted 
TM7 proteins were less than 30% homologous to previously sequenced proteins (Marcy 
et al., 2007).  The most recent and most complete genome of TM7 from the human oral 
cavity was obtained by utilizing the genomic data of TM7a as a scaffold for 454 
pyrosequencing (Liu et al., 2012).  This resulted in the identification of an additional 703 
genes that were not recovered by Marcy et al. (2007); however, the genome is still 
incomplete.  The most recent and most complete genome from activated wastewater was 
obtained by utilizing the Illumina HiSeq2000 sequencing platform (Albertsen et al., 
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2013).  The average TM7 genome size was determined to be 1 Mbp, which is close to the 
lower limit of free-living bacteria  (Albertsen et al., 2013). 
Protein analysis from the identified genes provides insight to the metabolic and 
physiological properties of TM7.  Physiological properties include the H+ anti-porter, 
involved in drug resistance, as well as cytochrome p450, which provides resistance to 
toxic compounds (Marcy et al., 2007).  Gene products for the type IV secretion system 
were also present.  The type IV system plays a role in the uptake of plasmids, potentially 
providing the cell with antibiotic resistance (Marcy et al., 2007; Albertsen et al., 2013).  
Type IV pili genes were discovered potentially providing the bacterium the means of 
adherence to endothelial cells, as well as a means to contribute in biofilm formation.  
Furthermore, Type IV pili are known to provide gliding motility in gram-positive bacteria, 
further suggesting TM7’s gram-positive origin (Marcy et al., 2007; Albertsen et al. 2013).  
Metabolic genes discovered include those involved in: ATP synthesis, glycolysis, the 
tricarboxylic acid cycle, and salvage pathways (Marcy et al., 2007).  However, the 
completed genome of TM7 in activated wastewater suggests that TM7 can only use the 
pentose phosphate and heterolactic fermentation pathways. (Albertsen et al. 2013) 
Molecular Methods for the Detection and Quantification of TM7 
 
 TM7 bacteria account for approximately 0.3% of the total bacterial population in 
the human oral cavity (Brinig et al., 2003).  Therefore, it is important to perform an 
efficient genomic DNA (gDNA) extraction to ensure the presence of such rare bacteria in 
the extracted sample.  Furthermore, the presence of contaminants must be limited due to 
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known inhibitory properties during PCR amplification of the 16S rRNA gene.  For 
instance, contaminants in soil and wastewater such as humic acids inhibit polymerase 
activity. In addition, humic acids are commonly found in DNA extractions as they have a 
similar charge to DNA (Yeates et al., 2003).  Therefore, following DNA extraction the 
purity of DNA must be determined using a spectrophotometer to ensure the absence of 
contaminants.  Using a spectrophotometer, a 260/230 nm ratio above 2 indicates pure 
DNA, while lower values suggest the possibility of contamination by compounds such as 
humic acid.  In addition, the 260/280 nm ratio can indicate the presence of protein 
contamination in the DNA extraction.  A 260/280 nm value of 1.8 is indicative of pure 
DNA, however as the ratio increases so does the relative abundance of protein 
contamination (Yeates et al., 2003). 
The DNeasy blood and tissue kit (Qiagen, Valencia, CA) is commonly utilized to 
perform genomic DNA extractions from various human anatomical sites.  This kit has 
been successfully utilized to obtain TM7 gDNA from the oral cavity (Dinis et al., 2011).  
That same study used the suggested modified protocol included in the kit for gram-
positive bacterium as TM7 is thought to be gram-positive-like (Hugenholtz et al., 2001).  
The gram-positive protocol makes use of chemical means to lyse the bacterial cells.  The 
principal component is lysozyme, which catalyzes the hydrolysis of N-acetylmuramic 
acid and N-acetyl-D-glucosamine residues, abundant components of the peptidoglycan 
cell wall of gram-positive bacteria (Mckenzie and White, 1991).  The gDNA is then 
isolated by ethanol precipitation (Yeates et al., 2003). 
  
10 
PCR and Cloning 
 
Once pure gDNA is obtained, the 16S rRNA gene is amplified using PCR, then 
PCR amplicons are cloned into Escherichia coli cells. TM7 16S rRNA sequences were 
originally obtained in 2001 in a study utilizing PCR with general bacteria primers BAC 
8F and BAC 1492R (Hugenholtz et al., 2001).  These general bacterial primers target a 
large proportion of the bacterial community (DeLong, 1992) and TM7 sequences were 
detected within that community.  To target TM7 specifically, a TM7 primer was created 
known as TM7 1177R (Brinig et al., 2003).  In combination, the BAC 8F and TM7 
1177R primer pair has been utilized to PCR amplify TM7 16S rRNA genes, of about 
1,189 base pairs, in a variety of samples (Brinig et al., 2003; Dinis et al., 2011).  PCR 
reactions utilizing these primers was performed using Taq DNA polymerase and an 
annealing temperature of 64°C (Brinig et al., 2003).  The resulting PCR products were 
cloned using the TOPO-TA cloning kit in combination with TOP10 chemically 
competent E. coli cells (Invitrogen, Carlsbad, California).  The clone library generated 
was then screened for clones with the correct insert size (~1,189 bp) via PCR and 
plasmids were extracted from each positive clone. 
16S rRNA sequencing and Phylogenetic Analysis 
 
BigDye sequencing methods (e.g. Sanger sequencing) have been widely used to 
obtain 16S rRNA gene sequences (Applied Biosystems, Foster City, California).  To 
retrieve the entire sequence of the PCR amplicon cloned, vector-specific primers (M13F 
and M13R) are used (Paster et al., 2001). 
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The first step in DNA sequence analysis is to clean each raw DNA sequence file 
of poor-quality nucleotide bases. The nucleotide quality is obtained from the 
chromatograms generated during sequencing.  The chromatogram is a representation of 
the DNA sequence.  It presents the relative signal strength of each DNA base (adenine, 
cytosine, thiamine, and guanine), which determines the position of nucleotides within the 
sequence (CodonCode Corporation, 2009).  There are multiple programs to aid in the 
cleaning process of DNA sequences.  CodonCode Aligner (CodonCode Corporation, 
Dedham, Massachusetts) is a program that will automatically remove portions of the 
DNA sequence with weak or mixed signals.  CodonCode Aligner can also remove vector 
sequence, improving the overall quality of the insert. 
Once sequences are cleaned they must be compared to a database to confirm their 
TM7 identity. The National Center for Biotechnology Information (NCBI) contains the 
GenBank database that houses non-redundant DNA sequences (Altschul et al., 1997) 
which includes thousands of 16S rRNA genes.  NCBI Basic Local Alignment Search 
Tool (BLAST) can be utilized to compare users’ sequences to those housed in GenBank.  
The BLAST tool allows users to determine the similarity or novelty of their sequences 
(Altschul et al., 1997). 
 In order to conduct a phylogenetic analysis, the DNA sequences must be aligned 
and compared.  The Greengenes database only houses 16S rRNA gene sequences and 
provides multiple tools for sequence preparation (DeSantis et al., 2006).  The Near 
Alignment Space Termination (NAST) tool is one such program that aligns 16S rDNA 
sequences to a 7,682-character scaffold, allowing for a systematic approach for 16S 
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rDNA comparisons (DeSantis Jr et al., 2006).  This scaffold was created using 10,000 
representative 16S rRNA genes from the Greengenes database.  Furthermore, the 
Greengene database provides chimera checking utilizing Bellerophon.  A chimera is an 
artifact of PCR, which contains multiple sequencing fragments from different organisms 
in a single sequence (Cole et al., 2003).  Bellerophon screens the user-imported 
sequences for the presence of chimeras (Cole et al., 2003).  Chimeric sequences are 
subsequently discarded from the analysis. 
Phylogenetic relationships of 16S rRNA genes are performed by software such as 
ARB.  ARB is an open source software that allows the comparison of 16S rRNA (Ludwig 
et al., 2004).  ARB compares both the primary and secondary structure of 16S rRNA 
gene sequences to 236,469 reference sequences making it the most powerful software to 
conduct rRNA comparisons.  Phylogenetic trees can be constructed within the ARB 
software by using a neighbor-joining algorithm.  In this algorithm, each organism is 
placed in an individual branch (Ludwig et al., 2004).  A ‘node’ signifies the location 
where the branches separate.  Because Neighbor-joining trees assume a molecular clock, 
each node signifies a common ancestor (Ludwig et al., 2004).  The branch lengths depict 
the organism divergence to its common ancestor, based on nucleotide mutations.  The 
longer the branch, the more divergent the two organisms are from one another (Ludwig et 
al., 2004).  Furthermore, the probability that each node occurred is signified by a 
bootstrap value (Ludwig et al., 2004).  Repeating the generation of the tree at least 100 
times derives a bootstrap value, which is the percentage that the node occurred at a 
particular location (Ludwig et al., 2004).  Finally, to increase the bootstrap values, thus 
13 
the accuracy of the tree, a distantly related sequence is added to root the tree (Ludwig et 
al., 2004).  This root allows all sequences to be compared to a single common ancestor. 
  
14 
Quantitative PCR 
 
Quantitative polymerase chain reaction (qPCR) utilizes fluorescently labeled 
probes or dyes in order to determine the absolute quantity of a target nucleic acid 
sequence (Applied Biosystems, 2005).  Quantification of nucleic acid targets in real time 
is possible in qPCR by fluorescence readings that are taken at the end of every PCR cycle.  
There are two main methods in which fluorescence can be detected by the qPCR 
thermalcycler; the first utilizes nucleic acid dyes, and the second uses fluorescently 
labeled probes (Applied Biosystems, 2005). 
 In the first method, a fluorescently labeled dye such as SYBR green is responsible 
for the fluorescence of target nucleic acids.  SYBR green is a general nucleic acid stain 
that binds to double-stranded DNA (dsDNA) but not single-stranded DNA (ssDNA) 
(Applied Biosystems, 2005).  Due to this feature, SYBR green will bind only to newly 
synthesized dsDNA amplicons at the end of each PCR cycle but will not bind and 
fluoresce ssDNA such as primers or probes.  According to Applied Biosystems, this 
method is preferred for determining the abundance of a sample with a known DNA 
composition such as a purified plasmid; however, it is not suitable for samples that 
contain a variety of unknown sequences, such as those obtained from genomic DNA 
extractions from environmental or human-associated mixed microbial communities.  This 
is because SYBR green is a non-specific dye, binding to any double-stranded nucleic acid, 
including non-specific PCR products, thus overestimating the targets’ true abundance. 
 In the second and more precise method, a TaqMan Probe assay is utilized.  A 
TaqMan probe is an oligonucleotide probe that is complementary to the target DNA 
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strand and is used for inducing fluorescence to the target amplicon (Applied Biosystems, 
2005).  The TaqMan probe is tethered to a fluorescent reporter on its 5’ end and a 
quencher on the 3’ end.  When excited by a light source of correct wavelength, the 
fluorescent reporter emits energy in the form of light (fluorescence) that can be detected 
by the qPCR machine (Applied Biosystems, 2005).  However, the Applied Biosystems 
manual states that while the quencher remains attached to the probe, the quencher absorbs 
the emitted light from the reporter, fluorescence is not produced, preventing the detection 
of the probe.  In order for the reporter to be detected, it must be cleaved from the probe.  
In addition to the fluorescent probe, TaqMan uses two primers that, like PCR, flank the 
piece of DNA to be amplified. The TaqMan probe is designed to bind to a DNA target 
sequence between the two primers.  During qPCR, all intact probes do not fluoresce due 
to the presence of the quencher, however, as Taq Polymerase elongates a target amplicon, 
the polymerase will reach the probe bound to DNA and will cleave the reporter from the 
attached probe, the fluorescence from the reporter is no longer quenched, allowing for its 
detection (Applied Biosystems, 2005).  As the qPCR cycles progress, more probes are 
cleaved and more fluorescence signal is produced. Hence, qPCR is a quantitative method 
because the amount of fluorescence detected is linked to the amount of a particular target 
DNA in a sample. As with FISH probes, TaqMan probes can be designed to target a 
variety of sample sizes.  Broad range probes such as BAC 338 have been designed to 
target most prokaryotes (Murray et al., 1998), and specific probes such as TM7a 1033 
have been designed to target a specific clade of TM7, TM7a (Dinis et al., 2011).  In order 
to prevent possible fluctuations between qPCR reactions caused by pipetting or 
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concentration errors, the ABI mastermix provides a passive reference dye.  The passive 
reference dye is utilized to normalize reporter detection fluctuations between qPCR 
reactions (Applied Biosystems, 2005).  
Utilizing qPCR to detect the abundance of TM7 has been performed previously 
(Brinig et al., 2003; Dinis et al., 2011).   Brinig et al. (2003), developed a protocol for the 
quantification of total bacteria and TM7 specific populations in Human subgingival 
crevice samples.   In this study, broad range 16S primers, BAC 8F and BAC 515R (Lane 
et al., 1985), were used in conjunction with TaqMan probe BAC 338 (Murray et al., 
1998) for total bacterial quantification.  TM7 quantities were determined by utilizing 
TM7 specific primers, TM7 910F and TM7 1177R in conjunction with TaqMan probe 
TM7 1093 (Brinig et al., 2003).  Thermocycling conditions in this study were preformed 
according to Applied Biosystems protocols with a modification to the annealing 
temperatures.  The total bacteria quantification reaction utilized three separate annealing 
temperatures: 55°C, 60°C, and 65°C (Brinig et al., 2003). The TM7 quantification 
reactions used a single annealing temperature of 61°C (Brinig et al., 2003).  In order to 
define the quantification of bacteria within the samples, a standard curve was generated 
utilizing a plasmid with a known copy number and was serially diluted.  The plasmid 
utilized for the generation of the standard curve encompassed a TM7 sequence that 
contained complimentary targets to all primers and probes utilized in the study (Brinig et 
al., 2003).  
Once rRNA gene copy numbers are obtained by the qPCR reaction, they must be 
converted to cells per gram.  Factored in that conversion is the fact that some prokaryotic 
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genomes contain more than one copy of the same 16S rRNA gene, some containing up to 
15 16S rRNA gene copies per cell (Acinas et al., 2004).  Based on analyses of complete 
bacterial genomes, it was determined that the average bacterium contains 3.5 16S rRNA 
genes per cell (Acinas et al., 2004).  Based on the two published TM7 genomes, TM7 
appear to have two 16S rRNA gene copies per cell (Marcy et al., 2007; Podar et al., 
2007). Therefore, a 3.5 16S rRNA gene copy number per cell was used when quantifying 
bacteria, and two copy numbers was be used when quantifying TM7. 
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Materials and Methods 
 
Patient Selection 
 
Six healthy individuals were selected randomly to participate in this study. The 
patients were chosen based on their availability to be sampled by the dentist.  In 
compliance with the Institutional Review Board (IRB) #F0904009, each patient was 
asked to sign a consent form and then asked to fill out an overall health survey (Table 2).  
Once the surveys were collected, each individual was given a randomly generated ID 
number to protect patient identity. 
Sample Collection and Processing 
 
A local licensed dentist first determined the health condition of each patient’s 
tooth based on quantitative (measurements of pocket depths, Figure 1) and qualitative 
(general observations of oral tissue health) observations.  Then, the same dentist used 
sterile techniques to collect all oral plaque samples with dental picks (Figure 1).  Five to 
six individual teeth were sampled from each patient.  The subgingival plaque sample 
from each tooth was notarized based on the tooth’s position, anatomical location, and 
sampling surface (facial or lingual) (Figure 2).  Each individual tooth’s collected oral 
plaque was put into individual 1.5 mL sterile eppendorf tubes (Eppendorf, Hauppauge, 
NY).  Each tube contained 200 μl sterile 1x PBS solution, was pre-weighed in a Mettler 
Toledo AB54-S balance (Mettler Toledo, Columbus, OH), and labeled with the patients 
ID followed by the tube number (1 - 6).  Hence, each tube had a unique number linked 
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to the patient and the exact tooth from which the plaque was collected. 
 
 
Figure 1.  Use of probe to measure periodontal pocket depth (nidcr.nig.gov, 2013).  The 
depth of each periodontal pocket was measured as shown to determine the health status of 
each tooth. 
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Figure 2.  Universal tooth numbering chart (DentalImplants-USA, 2013).  Each number 
represents a unique tooth.  Teeth are categorized based on their anatomical position, 
posterior (#1-5, 12 - 21, 28 - 32) or anterior (#6 – 11, 22 – 27), and sampling surface, 
facial (side of tooth facing the cheek) or lingual (side of tooth facing the tongue). 
  
21 
Samples were transferred to the laboratory on ice, and processed within 1 h of 
sampling.  Each tube was weighed again in a Mettler Toledo AB54-S balance (Mettler 
Toledo, Columbus, OH) to determine the net weight of collected oral plaque per sample.  
After each sample’s weight was determined, DNA was immediately extracted. 
DNA Extraction 
 
Bacterial genomic DNA was extracted from each sample using a Qiagen DNeasy 
Blood and Tissue Kit (Qiagen, Valencia, California).  DNA was extracted according to 
the manufacturer’s gram-positive bacteria protocol (protocol revision 07/2006).  
Following DNA extraction, concentration and purity of DNA was determined using a 
Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Waltham, MA) with version 
3.7 software (Thermo Scientific, Waltham, MA).  All extracted nucleic acid was stored at 
-20°C. 
Bacteria 16S rRNA Gene Amplification 
 
 To determine if the bacterial genomic DNA was successfully extracted, PCR was 
run to screen each sample for the presence of the 16S rRNA gene.  Broad-range primers 
BAC 8F and 515R were used to amplify the 16S rRNA target (Table 1).  PCR 
amplification was performed using a 1/10 dilution of each extracted sample.  Each 
individual 25 µl PCR reaction contained the following reagents: 2.5x10
-2
 units of GOTaq 
Flexi DNA polymerase (Promega, Madison, Wisconsin), 1x GOTaq Reaction Buffer 
(Promega, Madison, Wisconsin), 2.0 mM MgCl2, 0.2 mM of each deoxyribonucleotide, 
0.2 μM of each forward and reverse primer, and 5 to 50 ng of nucleic acid.  The PCR 
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reactions were carried out using an Applied Biosystemes 2720 Thermal Cycler (Applied 
Biosystems, Foster City, California) with the following cycling conditions: initial 
denaturation step of 95°C for 2 min then 35 cycles of 95°C for 30 sec, 55°C for 30 sec, 
and 72°C for 1.5 min, followed by a final elongation step of 72°C for 5 min. 
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Table 1. Primers and Probes 
General 
Bacteria 
BAC 8F PCR Primer AGA GTT TGA TCM TGG CTC AG 
BAC 515R PCR Primer KAC CGC GGC KGC TGG CA 
BAC 338I qPCR Probe GCT GCC TCC CGT AGG AGT 
BAC 338II qPCR Probe GCA GCC ACC CGT AGG TGT 
BAC 338III qPCR Probe GCT GCC ACC CGT AGG TGT 
TM7 910F PCR Primer CAT AAA GGA ATT GAC GGG GAC 
General 
TM7 
TM7 1177R PCR Primer GAC CTG ACA TCA TCC CCT CCT TCC 
TM7 1093 qPCR Probe AGT CCA TCA ACG AGC GCA ACC 
TM7a 997F PCR Primer TCC CGA GAA GAT TTA CG 
TM7a 
Specific 
TM7 1177R PCR Primer GAC CTG ACA TCA TCC CCT CCT TCC 
TM7a 1033 qPCR Probe ATC TGT CAC CGA GTT CCA 
 
 
Following PCR amplification, amplicons were run on a 1.5% agarose gel 
(International Biotechnologies Inc., New Haven, Connecticut) containing 0.025% 
Ethidium Bromide.  Gels were casted on a Horizon 58 gel electrophoresis system 
(Invitrogen, Carlsbad, California) with a FB300 electrophoresis power supply (Fisher 
Scientific, Waltham, Massachusetts), running at 90 V and 400 mA for 30 min.  Following 
electrophoresis, gel visualization and imaging was performed on a Bio-Rad Universal 
Hood II system (Bio-Rad, Hercules, California), and annotated using Quantity One 
Version 4.6 Software (Bio-Rad, Hercules, California). 
  
24 
Quantitative PCR 
 
Quantitative PCR (qPCR) was performed on all samples that tested positive for 
the presence of 16S rDNA using PCR as described above.  A TaqMan probe-based 
absolute quantification assay was performed on an Applied Biosystems 7300 Real Time 
PCR System (Applied Biosystems, Foster City, California).  For each oral sample, three 
subgroups of prokaryotes were quantified using qPCR: total bacteria, total TM7, and total 
TM7a.  Each experiment was run three times to generate an average, and each oral 
sample was run in triplicate per experiment, for a total of nine data points per oral sample. 
As part of the absolute quantification assay a standard curve was generated for each run 
to determine the amount of 16S rDNA in the samples.  
 In order to generate a standard curve, a positive control plasmid was utilized that 
contained complimentary targets for all qPCR primers and probes used in this study.  The 
concentration of the positive control plasmid was determined using a Nanodrop ND-1000 
spectrophotometer (Thermo Scientific, Waltham, MA) and diluted to a final 
concentration of 5.6 ng/ul, which correlates to be 1x10
9
 molecules of plasmid per ul.  For 
the generation of each standard curve the positive control plasmid was serially diluted 
from 1x10
8
 to 1 plasmid copy number(s) per ul, hence each standard curve had eight data 
points.  As with oral samples, each plasmid dilution was run in triplicate for each of the 
three experimental runs. 
 Experimental setup including annotating the standard curve controls and oral 
samples was performed with the 7300 System SDS software version 1.4 (Applied 
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Biosystems, Foster City, California) using the absolute quantification platform.  
Experimental parameters and cycling conditions were as follows for each of the three 
phylogenetic groups targeted: 
Bacterial quantification.  Each qPCR reaction contained a final volume of 20 μl 
composed of 10 μl TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied 
Biosystems, Foster City, California), 1.8 μM of the forward primer BAC 8F, 3.6 μM of 
the reverse primer BAC 515R, and contained 0.1 μM of each of the following TaqMan 
probes: BAC 338I, BAC 338II, and BAC 338III (Table 1).  The TaqMan probes 
contained a FAM fluorescent reporter and a black hole quencher.  Cycling parameters 
were defined as follows: initial denaturation and Taq activation step of 95°C for 10 min, 
then 45 cycles of 95°C for 30 sec, 55°C for 30 sec, 60°C for 45 sec, 65°C for 15 sec, and 
72°C for 30 sec as previously published (Brinig et al. 2003).  At the end of each 72°C 
elongation step, fluorescent levels were read and recorded automatically by the qPCR 
machine. 
 
TM7 quantification.  Each qPCR reaction contained a final volume of 20 μl 
composed of 10 μl TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied 
Biosystems, Foster City, California), 0.9 μM of the forward primer TM7 910F, 0.9 μM of 
the reverse primer TM7 1177R, and 0.1 μM of TaqMan probe TM7 1093 containing a 
FAM fluorescent reporter and black hole quencher (Table 1).  Cycling parameters were 
defined as follows: initial denaturation and Taq activation step of 95°C for 10 min, then 
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45 cycles of 95°C for 30 sec, 61°C for 30 sec, and 72°C for 30 sec.  At the end of each 
72°C elongation step, fluorescent levels were read and recorded. 
TM7a quantification.  Each qPCR reaction had a final volume of 20 μl composed of 10 
μl TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied Biosystems, Foster 
City, California), 0.9 μM of the forward primer TM7a 997F, 0.9 μM of the reverse primer 
TM7 1177R, and 0.1 μM of TaqMan probe TM7a 1033 containing a FAM fluorescent 
reporter and black hole quencher (Table 1).  Cycling parameters were defined as follows: 
initial denaturation and Taq activation step of 95°C for 10 min, then 45 cycles of 95°C 
for 30 sec, 61°C for 30 sec, and 72°C for 30 sec.  At the end of each 72°C elongation step, 
fluorescent levels were read and recorded. 
qPCR Raw Data Conversions 
 
Following each run, the quantification of targeted 16S rRNA genes was obtained, 
commonly referred to as gene copy number.  Because each sample starting material 
(plaque) was of different weight, measurements were normalized by the original plaque 
weight in order to compare the quantification of 16S rRNA gene copy number among the 
various samples. In addition the number of 16S rRNA genes in a bacterial genome varies 
depending on the phylogenetic group. Therefore, an equation was used to convert total 
16S rRNA genes to cells/g of pelleted oral plaque (Figure 3).  The following conversion 
was performed to obtain cells/g of pelleted oral plaque from the raw qPCR data: 1) 
Corrections for gene copy number per cell, using an estimated 3.5 average rRNA gene 
copy number per cell for total bacteria quantification (Klappenbach et al., 2001) and 2.0 
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average rRNA gene copy number per cell for total TM7 and TM7a (Marcy et al., 2007; 
Podar et al., 2007), 2) corrections for DNA sample dilution used for qPCR reactions, and 
3) corrections for DNA concentration due to DNA extraction methods. 
 
 
 
 
Figure 3.  Calculation for converting raw qPCR data, rRNA gene copy number/μl, to 
cells/g of pelleted oral plaque.  Conversions included corrections for gene copy number 
per cell, sample dilution used, and changes in volume during DNA extraction. 
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Results 
 
Patient Selection 
 
Four males and two females participated in this study (Table 2).  The average patient was 
in their mid twenties.  Two patients were current or previous smokers.  All patients 
brushed their teeth twice daily; however, the frequency of dental flossing ranged from 1 – 
7 times per week.  Two patients experienced bleeding upon flossing.  Three patients bit 
their fingernails, and no patients had extensive crown or bridge work. 
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Table 2.  Summary of patient health surveys.  All reports were collected the day of plaque 
collection 
 
Patient ID 
 
DXD ETP FYZ GMO KPM JNW 
Gender F M M M M F 
Age 26 - 30 31 + 21 - 25 21 - 25 26 - 30 21 - 25 
Height 5'3' 5'10" 6'0" 5'10" 6'0" 5'4" 
Weight - 178 170 130 165 104 
Health 
condition 
No No No No No No 
Smoker Yes No No No Yes No 
Allergies Yes No No No Yes No 
Brush 
Frequency 
2x 2x 2x 2x 2x 2x 
Floss 7x 6x 5x 1x 7x 5x 
Bleeding Gums Yes No Yes No No Yes 
Finger Biting No No Yes No Yes Yes 
Extensive 
Crown or 
Bridge Work 
No No No No No No 
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Sample Collection and Processing 
 
Between five and six oral plaque samples were collected from each of the six 
patients for a total of 34 samples (Table 3). An average of 0.0028 g of dental plaque was 
collected from each sample with a range from 0.0013 g to 0.0048 g (Table 3).  Among 
the 34 samples, 23 were from males and 11 from females. The sites from which samples 
were collected included 19 from the facial side and 15 from lingual, whereas 23 samples 
were from posterior sites and 11 from anterior sites (Table 3).  Pocket depth (PD) was 
used as a preliminary measure of the gingival health status.  PD ≤ 3 mm are considered 
healthy, whereas PD ≥ 4 are considered unhealthy (or diseased). The average PD among 
all sampled sites was 2.7 mm with a range from 2 mm to 5 mm.  Thirty sites were 
classified as healthy (PD ≤ 3 mm) and four sites exhibited gingivitis (PD ≥ 4) (Table 3). 
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Table 3. Subgingival Plaque Weights.  Each tube used to collect the samples was labeled and filled with 200 μl sterile H2O and 
weighed to obtain the initial tubes weight.  Following sample collection, each tube was weighed a second time to determine the 
weight of the subgingival plaque.  Pocket depth was determined by the dentist prior to collecting the sample. 
 
Patient 
 
DXD ETP 
Sample 1 2 3 4 5 6 1 2 3 4 5 6 
Tooth 2F 6F 13L 19L 24F 31F 2F 5F 8L 30L 27F 13F 
Tube   
(g) 
1.0070 1.0033 1.0129 1.0040 1.0021 1.0052 1.0036 1.0079 1.0071 1.0077 1.0035 1.0044 
Tube 
w/sample 
(g) 
1.0091 1.0068 1.0158 1.0061 1.0043 1.0075 1.0057 1.0099 1.0094 1.0099 1.0058 1.0077 
Sample    
(g) 
0.0021 0.0035 0.0029 0.0021 0.0022 0.0023 0.0021 0.0020 0.0023 0.0022 0.0023 0.0033 
Pocket    
Depth      
(mm) 
3 3 3 2 3 2 2 5 3 3 2 3 
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Table 3. Subgingival Plaque Weights, continued. 
 
Patient 
 
FYZ GMO 
Sample 1 2 3 4 5 6 1 2 3 4 5 6 
Tooth 2F 7L 13F 31F 25F 20L 2F 8F 15L 20L 26F 31F 
Tube (g) 1.0129 0.9895 1.0026 1.0075 1.0051 1.0004 1.0126 1.0212 1.0064 1.0082 1.0039 1.0043 
Tube 
w/sample 
(g) 
1.0161 0.9918 1.0052 1.0107 1.0084 1.0034 1.0153 1.0244 1.0107 1.0107 1.0087 1.0076 
Sample    
(g) 
0.0032 0.0023 0.0026 0.0032 0.0033 0.0030 0.0027 0.0032 0.0043 0.0025 0.0048 0.0033 
Pocket    
Depth      
(mm) 
3 2 4 4 2 4 2 3 2 3 3 2 
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Table 3. Subgingival Plaque Weights continued. 
 
 Patient 
 JNW KPM 
Sample 1 2 3 4 5 1 2 3 4 5 
Tooth 4L 10L 20L 24F 30L 2F 20L 18L 31L 11F 
Tube   
(g) 
1.0006 0.9890 1.0057 1.0039 1.0033 1.0062 1.0046 1.0044 1.0038 1.0122 
Tube 
w/sample 
(g) 
1.0043 0.9918 1.0081 1.0071 1.0069 1.0095 1.0081 1.0066 1.0051 1.0136 
Sample    
(g) 
0.0037 0.0028 0.0024 0.0032 0.0036 0.0033 0.0035 0.0022 0.0013 0.0014 
Pocket    
Depth      
(mm) 
3 2 3 3 3 3 2 3 2 2 
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DNA Extraction 
 
Genomic DNA extracted yielded an average of 14.27 ng/μl with a range of 1.62 
ng/μl - 51.34 ng/μl (Table 4).  DNA purity was determined by the A260/A280 ratio, 
which averaged 1.90±0.30, indicating that the extracted DNA contained predominantly 
DNA (Table 4).   
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Table 4.  Genomic DNA Extraction.  Extractions were performed using the Qiagen DNeasy Blood and Tissue Kit.  DNA 
concentration expressed in ng/μl using a NanoDrop spectrophotometer.  DNA purity is expressed as the A260/A280 ratio. 
Tooth # followed the standard numbering of teeth used in dentistry.  F = facial and L = lingual side of the tooth. 
 
Patient 
 
DXD ETP JNW 
Sample 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 
Tooth 2F 6F 13L 19L 24F 31F 2F 5F 8L 30L 27F 13F 4L 10L 20L 24F 30L 
ng/μl 24.94 19.46 12.22 26.86 9.67 18.63 1.62 6.05 9.65 9.03 3.07 12.63 6.69 7.26 13.65 4.46 13.54 
A260/A280 
Ratio 
1.93 1.95 1.92 1.92 1.81 2.03 1.71 1.69 2.57 1.81 2.14 1.86 2.14 1.5 1.5 2.16 1.82 
 
Table 4. Genomic DNA Extraction Continued. 
 
Patient 
 
FYZ GMO KPM 
Sample 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 
Tooth 2F 7L 13F 31F 25F 20L 2F 8F 15L 20L 26F 31F 2F 20L 18L 31L 11F 
ng/μl 20.37 9.38 20.22 9.07 15.57 26.95 19.67 20.56 16.62 13.36 51.34 28.68 6.8 10.49 4.98 4.08 7.65 
A260/A280 
Ratio 
1.81 1.43 1.74 1.67 1.93 1.72 1.89 1.95 2.02 1.85 2.09 1.95 2.97 1.65 1.8 1.38 2.12 
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Bacteria 16S rRNA Gene Amplification 
 
Initial PCR screening showed that all 34 oral samples contained the 16S rRNA 
gene from bacteria as determined from amplifying samples with general bacteria 16S 
rRNA primers, BAC 8F and BAC 515R.  All samples were compared to a positive 
control plasmid in a 1.5% agarose gel.  A 1/10 dilution of all DNA samples was used to 
conserve DNA (Figure 4). 
 
 
 
Figure 4.  PCR screening results from extracted genomic DNA using BAC 8F and BAC 
515R.  A 1/10 dilution of each genomic DNA sample was used. PCR products were run 
on a 1.5% agarose gel with a low range ladder and positive control plasmid as a reference. 
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Quantitative PCR 
 
Real time quantitative PCR was used to quantify the 16S rRNA gene in each oral 
plaque sample.  Three separate qPCR assays were performed to quantify the i) total 
bacteria, ii) TM7, and iii) TM7a populations.  qPCR quantification was based on a 
standard curve generated using a positive control plasmid serially diluted from 10
8
 to 1 
gene copy number per μl.  At the end of each run, the ABI 7300 qPCR software produced 
a best-fit line using five sequential dilution points of the standard curve (Table 5).  From 
the slope of the best-fit line the coefficient of correlation (R
2
) was calculated.  The ideal 
qPCR run (100% efficiency) has a slope of -3.33 and an R
2 
of 100%, indicating each 16S 
rDNA gene in the sample was copied (doubled) every qPCR cycle.   For all three qPCR 
target groups in the oral samples (Bacteria TM7 and TM7a) the R
2
 values were greater 
than 99% (Table 5), signifying high accuracy of results.  The normalized data collected 
over three runs produced amplification efficiencies near the ideal value of one (Table 5).  
Among the six patients, all were positive for the presence of bacteria as expected.  TM7 
was detected in all patients and in 32 of 34 (94.1%) samples.  TM7a was detected in 5 of 
6 (83%) patients and in 22 of 34 (64.7%) samples.  
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Table 5.  Amplification efficiency values from qPCR experiments.  Each assay consisted 
of three runs in triplicates per sample, total sample population (n = 9).  Numbers in 
parenthesis are ± standard error of the mean. 
 
qPCR Assay 
Target 
Amplification 
Efficiency 
Slope R
2
 
Standard 
Range 
Bacteria 0.96 (0.013) 3.42 (0.035) >99% 10
4
 - 10
8
 
TM7 0.95 (0.022) 3.46 (0.036) >99% 10
3
 - 10
7
 
TM7a 0.99 (0.0024) 3.37 (0.0059) >99% 10
2
 - 10
6
 
 
While the concentration of bacteria was more consistent (small standard 
deviation), the concentrations of TM7 and TM7a in oral plaque were more dynamic from 
patient to patient (Table 6 and Figure 5).  Bacteria concentration ranged from 4.84x10
10
 
cells g
-1 
(Patient DXD) to 5.08x10
9 
cells g
-1 
 (Patient KPM) with an overall average of 
2.26x10
10 
± 9.24x10
9
 (mean ± s.e.m.; n = 6) cells g
-1
 (Figure 5).  TM7 counts ranged 
from 3.36x10
8
 cells g
-1
 (Patient FYZ) to 1.08x10
7
 cells g
-1
 (Patient ETP) with an overall 
average of 1.78x10
8 
± 9.21x10
6
 (n = 6) cells g
-1
 (Figure 5).  TM7a counts ranged from 
1.39x10
8
 (Patient DXD) to 5.10x10
4
 (Patient JNW) with an overall average of 3.36x10
7 
± 
2.53x10
6
 (n = 6) cells g
-1
 (Figure 5). 
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Figure 5. Average number of total bacteria, TM7, and TM7a, in human oral subgingival 
plaque.  Values represent the mean of all sampled teeth within the patient. 
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To understand if the concentrations of bacteria influence the total TM7 or TM7a 
populations, the relative abundance of TM7 and TM7a was calculated.  In other words, 
the concentrations of TM7 and TM7a were normalized to the total Bacteria concentration.  
In addition, TM7a was normalized to the total TM7 concentration. The average relative 
abundance of TM7 (average TM7/average bacteria) was 1.06% ± 0.025% (n = 32) with a 
range of 3.29% ± 1.58% (Patient JNW; n = 5) to 0.16% ± 0.10% (Patient ETP; n = 6) 
(Table 6).  The average relative abundance of TM7a to bacteria (average TM7a/average 
bacteria) was 7.59x10
-2
% ± 3.08x10
-2
% (n = 22) and to TM7 (average TM7a/average 
TM7) 18.19% ± 6.68% (Table 6).  The range of TM7a to bacteria was 2.88x10
-1
% ± 
2.16x10
-1
% (Patient DXD; n = 6) to 1.00X10
-3
% ± 8.65X10
-4
% (Patient JNW; n = 5), 
and to TM7 was 65.27% ± 51.58% (Patient DXD; n = 6) to 3.05x10
-2
% ± 2.69x10
-2
% 
(Patient JNW; n = 5) (Table 6).  
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Table 6. Quantification and relative abundance of TM7a based on qPCR assay.  
Percentage of TM7a from bacteria calculated as average TM7a (cells g
-1 
)/average 
bacteria (cells g
-1 
).  Percentage of TM7a of TM7 calculated as average TM7a             
(cells g
-1 
)/average TM7 (cells g
-1 
). 
 
 
Patient ID 
 
DXD ETP FYZ GMO JNW KPM 
TM7a 
Cells/g 
Human 
Oral 
Plaque    
(±S.E.M.) 
1.39x10
8
 
(2.74x10
7
) 
3.12x10
6
 
(1.32x10
6
) 
1.23x10
7
 
(2.33x10
6
) 
2.84x10
7
 
(6.77x10
6
) 
5.10x10
4
 
(2.68x10
4
) 
0 
Percent 
TM7a of 
Total 
Bacteria 
Population 
(±S.E.M.) 
2.88x10
-1
% 
(2.16x10
-1
%) 
4.61x10
-2
% 
(4.90x10
-2
%) 
5.20x10
-2
% 
(2.86x10
-2
%) 
6.83x10
-2
% 
(6.02x10
-2
%) 
1.00x10
-3
% 
(8.65x10
-4
%) 
0% 
Percent 
TM7a of 
Total TM7 
Population 
(±S.E.M.) 
65.27% 
(51.58%) 
28.92% 
(20.64%) 
3.67% 
(2.12%) 
8.81% 
(2.42%) 
3.05x10
-2
% 
(2.69x10
-2
%) 
0% 
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TM7 bacteria were present in all patients and in 32 of 34 (94.1%) samples, 
suggesting TM7 is ubiquitous in the human oral cavity; however, a larger sample size 
would be needed to confirm such finding. TM7a populations on the one hand, were not 
prevalent in all samples or patients, and the abundance of total bacteria or total TM7 did 
not influence the abundance of TM7a.  There was, however, a statistically significant 
difference in mean TM7a abundance between (p < 0.0005, t = 4.256, n = 34) facial sites 
(5.15x10
7 
± 9.49x10
6
; n = 19) and lingual sites (9.78x10
6 
± 2.01x10
6
; n = 15) (Figure 6).  
TM7a was ~5.3 times more abundant in sites facing the human cheeks than sites facing 
the tongue. TM7a was also significantly more abundant (p < 0.05, t = 2.162, n = 34) in 
posterior sites (3.95x10
7 
± 7.90x10
6
; n = 23) than in anterior sites (2.00x10
7 
± 4.36x10
6
; n 
= 11) (Figure 7).  TM7a was ~2 times more abundant in the front of the mouth as 
compared to the back. There was no observed statistical significance regarding the 
abundance of TM7a between healthy (3.70x10
7 
± 6.39x10
6
; n = 30) and gingival sites 
(8.12x10
6 
± 2.72x10
6
; n = 4) (Figure 8), even though TM7a was found to be ~4.5 times 
more abundant in healthy sites. Suggesting that there are other unidentified factors 
influencing the abundance and prevalence of TM7a in subgingival plaque. 
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Figure 6. Average number (cells g
-1 
) of TM7a cells from facial and lingual plaque 
samples. 
  
*
* p < 0.0005
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Figure 7. Average number of TM7a cells (cells g
-1 
) from anterior or posterior plaque 
samples. 
  
*
* p < 0.05
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Figure 8. Average number of TM7a cells (cells g
-1 
) from Healthy or Gingival plaque 
samples.  Health status determined by depth of periodontal pocket, classified as either 
healthy (PD ≤ 3) or gingival (PD ≥ 4). 
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Discussion 
 
Assay to Target TM7a in Human Subgingival Plaque 
 
TM7a has been detected in both environmental and human sites.  However, it has 
only been quantified in activated wastewater and not in human samples. In this study, the 
first quantification of TM7a in human oral plaque samples was performed. The 
environmental TM7a from wastewater has been named “TM7a-like” by its founders 
(Dinis et al. 2011).  The qPCR TaqMan assay to Target TM7a-like in activated 
wastewater used two primers (TM7a 997F and TM7a-like 1112R) plus one fluorescent 
probe (TM7a 1033).  In this study the same forward primer (TM7a 997F) and probe 
(TM7a 1033) as in Dinis et al. (2011) was used, but also a broad range TM7 reverse 
primer (TM7 1177R), which targets both TM7a and “TM7a-like” bacteria.  In addition, 
the qPCR assay used in this study, detects 25 TM7a phylotypes as compared to 20 TM7 
phylotypes detected with the reverse primer used in the Dinis et al. (2011) qPCR assay. 
This 25% increase in detection power to the qPCR assay can be significant if the 
proportion of the 5 newly detected TM7 phylotypes are predominant members in a 
particular sample site. 
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Quantification of TM7 and TM7a in Human Subgingival Plaque 
 
TM7 bacteria were present in all patients and in 32 of 34 (94.1%) samples.  This 
is consistent with a previous study surveying TM7 in human subgingival plaque, which 
detected TM7 in 86 of 90 (96%) samples (Brinig et al. 2003).  Results suggest the 
division TM7 is common in the human oral cavity and perhaps even a permanent resident.  
TM7a on the other hand, was detected in 5 of 6 (83%) patients and in 22 of 34 (64.7%) 
samples. The only previous quantification of TM7a was performed in activated 
wastewater (Dinis et al. 2011), which found “TM7a-like” in 4 of 23 (17.4%) samples, 
suggesting that the factors that contribute to the prevalence of TM7a may differ from 
other TM7 bacteria. 
The relative abundance of TM7 (average TM7/ average bacteria) from human 
subgingival plaque in this study was 1.06% ± 0.025% (SE), as compared to the previous 
study by Brinig et al. (2003), which found TM7 to make up 0.3% of the total bacteria 
community by real-time PCR.  Although the relative abundance of TM7 in this study is 
253% greater than found by Brinig et al. (2003), it is important to note the percentage of 
TM7 in the previous study was calculated based on the total rRNA copy number/μl, 
which did not take into account the normalization of average rRNA gene copy found in 
the TM7 and bacteria genomes (see figure 3) as performed in this study, and is therefore 
likely underestimated. The TM7 gene copy number was not available until 2007 (Marcy 
et al. 2007), three years after the first TM7 qPCR quantification by Brinig et al. (2003) 
was published.  
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The relative abundance of TM7a to bacteria (average TM7a/average bacteria) in 
this study was 7.59x10
-2
% ± 3.08x10
-2
% and to TM7 (average TM7a/average TM7) 
18.19% ± 6.68%.  TM7a has not been quantified in human oral samples, but based on the 
previous quantification of TM7a in activated wastewater (Dinis et al. 2011), “TM7a-like” 
was found to make up 0.01% of total bacteria and 0.44% of TM7. Although this is a pilot 
study, these limited data suggests that TM7a is present in greater percentage in 
subgingival plaque than in activated wastewater. 
Consistent with other studies, there was no correlation between the abundance of 
TM7 and gender, smoking status, or age (Brinig et al. 2003).  TM7a on the one hand was 
found to be significantly more abundant in posterior than anterior sites, as well as 
significantly more abundant in facial than lingual sites.  It is unknown as to what the 
contributing factors are that favor TM7a preference for these locations; however, an in-
depth look at the total bacterial composition at these sites may shed some light on the 
matter.  TM7a was also found to be more abundant in healthy samples; however, this 
finding was not statistically significant and is consistent with the previous study (Brinig 
et al. 2003) that found TM7 to be more abundant in gingival sites, but not statistically 
significant.  Both this study and the one performed by Brinig et al. (2003) had relatively 
small populations of gingival samples, 4 of 34 (11.8%) and 5 of 76 (6.6%), respectively.  
Perhaps with a larger sample size, the significance of TM7 and TM7a at these sites can 
be elucidated. 
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Future Directions 
 
The overall abundance of TM7 and TM7a were dynamic in human subgingival 
plaque.  Although the presence of TM7 was more consistent, the same could not be said 
about TM7a.  There are many factors, which can contribute to their prevalence including 
diet, health, and the bacterial composition at each site.  A future cross-sectional study 
quantifying TM7a in a more diverse population could provide more details on TM7a 
prevalence. Next-generation sequencing can identify the bacterial population from each 
sample and may reveal trends that favor the prevalence of TM7 and TM7a in human 
subgingival plaque. 
 In addition, a temporal study utilizing both a quantitative analysis and next-
generation sequencing can provide a glimpse of how the bacterial population changes, 
and how these changes reflect on the abundance and overall prevalence of TM7 and 
TM7a at each site. 
 
Conclusions 
 
In this pilot study, TM7a was successfully detected and quantified in human 
subgingival plaque.  Consistent with previous studies, TM7 was not found to be 
significantly more abundant in gingival samples as compared to healthy samples.  TM7a 
on the other hand was found to be significantly more abundant in facial sites as well as 
posterior sites as compared to lingual sites and anterior sites respectively.  A larger and 
50 
more diverse sample size, including a wider array of diseased samples is needed to make 
correlations between TM7a and human oral disease.  Here we presented an optimized 
assay that successfully quantified TM7a in human oral sites. 
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